The Drug-Induced Respiratory Disease Website
Typically acute. Can be fulminate/fulminant and fatal (PMID 30242316). General review at PMID 28540649. Recent addition to the lst of causal drugs include immune checkpoint inhibitors (PMID 28833116, 29801747)
Publications
Post-vaccine COVID-19 acute myocarditis: case reports and literature review.
The Pan African medical journal 2023;44;192 — 2023 — 192
Goddard K, Lewis N, Fireman B, Weintraub E, Shimabukuro T, Zerbo O, Boyce TG, Oster ME, Hanson KE, Donahue JG, Ross P, Naleway A, Nelson JC, Lewin B, Glanz JM, Williams JTB, Kharbanda EO, Katherine Yih W, Klein NP
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine 2022 Aug 19;40;5153-5159 — 2022 Aug 19 — 5153-5159
A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.
Journal of Korean medical science 2022 Apr 04;37;e104 — 2022 Apr 04 — e104
Transient Myopericarditis Following Vaccination for COVID-19.
Journal of medical cases 2022 Feb;13;80-84 — 2022 Feb — 80-84
Myocarditis post SARS-CoV-2 vaccination: a systematic review.
QJM : monthly journal of the Association of Physicians 2022 Mar 03;; — 2022 Mar 03
Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
Heart, lung & circulation 2022 Feb 25;; — 2022 Feb 25
A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination.
European heart journal. Case reports 2022 Jan;6;ytac004 — 2022 Jan — ytac004
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination.
Clinical case reports 2022 Feb;10;e05378 — 2022 Feb — e05378
Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis.
Frontiers in cardiovascular medicine 2021;8;769616 — 2021 — 769616
Naghashzadeh F, Shafaghi S, Dorudinia A, Naji SA, Marjani M, Amin A, Mohamadifar A, Noorali S, Kashani BS
Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
ESC heart failure 2022 Feb 01;; — 2022 Feb 01
Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine.
European heart journal. Case reports 2021 Aug;5;ytab319 — 2021 Aug — ytab319
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients.
International journal of cardiology 2021 Aug 18;; — 2021 Aug 18
Myocarditis with COVID-19 mRNA Vaccines.
Circulation 2021 Jul 20;; — 2021 Jul 20
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines.
Cureus 2021 Jun;13;e15576 — 2021 Jun — e15576
COVID-19 mRNA Vaccine and Myocarditis.
European journal of case reports in internal medicine 2021;8;002681 — 2021 — 002681
Acute myocarditis following administration of BNT162b2 vaccine.
IDCases 2021;25;e01197 — 2021 — e01197
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
JAMA cardiology 2021 Jun 29;; — 2021 Jun 29
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
JAMA cardiology 2021 Jun 29;; — 2021 Jun 29
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
BMJ (Clinical research ed.) 2021 Jun 24;373;n1635 — 2021 Jun 24 — n1635
Larson KF, Ammirati E, Adler ED, Cooper LT, Hong KN, Saponara G, Couri D, Cereda A, Procopio A, Cavalotti C, Oliva F, Sanna T, Ciconte VA, Onyango G, Holmes DR, Borgeson DD
Myocarditis after BNT162b2 and mRNA-1273 Vaccination.
Circulation 2021 Jun 16;; — 2021 Jun 16